Finally, as referred to before, RKIP was established as a metastasis suppressor for the first time in prostate cancer, where it was reported that low RKIP expression in primary tumors increases the probability of lung metastasis development [63], a finding that was further demonstrated for other tumors of different primary sites [102,103,104,105]. The gene discussed is PEBP1; the disease is prostate cancer.